"Co-Diagnostics, Inc. SARS-CoV-2 Test Used In New Community Surveillance Method In Italy",https://www.laboratorynetwork.com/doc/co-diagnostics-inc-sars-cov-test-used-in-new-community-surveillance-method-in-italy-0001,9/9/2021,"Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Italian researchers to confirm the presence of SARS-CoV-2, including mutated strains of the virus, in a community surveillance method of testing single-use waste, with the peer-reviewed results published in the journal Science of the Total Environment."
Promega Launches OncoMate MSI Dx Analysis System In US,https://www.laboratorynetwork.com/doc/promega-launches-oncomate-msi-dx-analysis-system-in-us-0001,9/8/2021,"Promega Corporation today launched its OncoMate MSI Dx Analysis System (OncoMate MSI)in vitro diagnostic (IVD) in the US, giving oncologists and pathologists a new option to screen for Lynch syndrome in patients with colorectal cancer."
New Mass Spectrometry Portfolio Leverages Enhanced Hardware And Software To Advance Quantitative Analysis,https://www.laboratorynetwork.com/doc/new-mass-spectrometry-portfolio-leverages-enhanced-hardware-and-software-to-advance-quantitative-analysis-0001,9/8/2021,"Lab managers, technology leaders and principal scientists in pharmaceutical, food and environmental laboratories can now benefit from accelerated throughput and improved sensitivity to meet rapidly changing regulatory requirements and provide the fast responses needed for tackling emerging human and environmental health risks."
Marshfield Clinic Health System Partners With 4medica To Modernize And Build Laboratory Reference And Outreach Business,https://www.laboratorynetwork.com/doc/marshfield-clinic-health-system-partners-with-medica-to-modernize-outreach-business-0001,9/8/2021,"Marshfield Clinic Health System, an integrated health system of 10 hospitals and more than 60 clinics throughout Wisconsin, has selected 4medica®as its strategic connectivity and data integrity partner to modernize the regional expansion of Marshfield Labs and its reference and outreach business line operations."
Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain’s Largest Clinical Group Quirónprevención,https://www.laboratorynetwork.com/doc/genetic-testing-pioneer-dnanudge-signs-key-agreement-with-spain-s-largest-clinical-group-0001,9/7/2021,Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection Of DNA Or RNA From Saliva Samples,https://www.laboratorynetwork.com/doc/meridian-launches-two-new-air-dryable-direct-detection-of-dna-or-rna-from-saliva-samples-0001,9/7/2021,"Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Saliva Mixes, which are designed for incorporation in room-temperature stable molecular assays, directly targeting nucleic acid sequence from saliva and sputum."
NuProbe Global Adopts Bionano’s Saphyr® System To Develop Products In Reproductive Health And Oncology Applications,https://www.laboratorynetwork.com/doc/nuprobe-global-adopts-develop-products-in-reproductive-health-and-oncology-applications-0001,9/7/2021,"Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies for research and product development in the fields of reproductive health and oncology liquid biopsies."
LexaGene’s MiQLab™ Accurately Detects Multiple Strains Of Pathogenic Bacteria In Polymicrobial Samples Compared To Conventional Culture,https://www.laboratorynetwork.com/doc/lexagene-s-miqlab-accurately-detects-multiple-strains-of-pathogenic-bacteria-into-conventional-culture-0001,9/7/2021,"LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it successfully utilized its MiQLab™ System (“MiQLab”) to detect the presence of multiple strains of pathogenic bacteria in polymicrobial samples that vary in their antimicrobial resistance (AMR)."
BGI's COVID-19 Test Laboratory At The Airport Secures Route Between Ethiopia And China,https://www.laboratorynetwork.com/doc/bgi-s-covid-test-laboratory-at-the-airport-secures-route-between-ethiopia-and-china-0001,9/6/2021,"From April to August 2021 , the BGI's COVID-19 testing lab helped 5,500 Chinese travelers fly safely from Addis Ababa Bole International Airport. In April, the BGI, in cooperation with Ethiopia Airlines, set up the ""Huo-Yan"" laboratory, a COVID-19 test laboratory, at the airport for passengers flying to China only flight was suspended."
Home Blood Collection Device Works For COVID Antibody Test,https://www.laboratorynetwork.com/doc/home-blood-collection-device-works-for-covid-antibody-test-0001,9/3/2021,"A device that could make it possible for patients to draw their own blood at home was successfully used to collect blood samples for measuring antibodies against SARS-CoV-2, the virus that causes COVID-19, researchers at the University of Washington School of Medicine in Seattle report."
NuProbe Global And Bionano To Co-Develop Products In Reproductive Health And Oncology Testing,https://www.laboratorynetwork.com/doc/nuprobe-global-and-bionano-to-co-develop-products-in-reproductive-health-and-oncology-testing-0001,9/1/2021,"NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, and Bionano Genomics, based in San Diego, California, have entered into a procurement and collaboration agreement, where NuProbe will integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies with Bionano's Saphyr system for research and product development in the fields of reproductive health and oncology liquid biopsies."
"Todos Medical’s CLIA/CAP Lab Provista Completes Validation Of Combination COVID, Influenza A & B, RSV & hMPV Respiratory Panel Test",https://www.laboratorynetwork.com/doc/todos-medical-s-clia-cap-lab-provista-completes-covid-influenza-a-b-rsv-hmpv-respiratory-panel-test-0001,9/1/2021,"Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the Quidel Lyra Influenza A & B and the Lyra RSV & hMPV PCR kits into production alongside COVID PCR tests currently being run (together the “Provista Respiratory Panel”) and expects this new respiratory panel to be launched in September 2021."
Natera Announces The Validation And Launch Of The Prospera™ Heart Transplant Assessment Test,https://www.laboratorynetwork.com/doc/natera-announces-the-validation-and-launch-of-the-prospera-heart-transplant-assessment-test-0001,8/31/2021,"Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, today announced the validation and clinical availability of its Prospera Heart transplant assessment test for heart transplant recipients."
BC Platforms Launches Packaged End-To-End Solution For NGS Laboratories With Sentieon To Accelerate Adoption Of NGS Testing,https://www.laboratorynetwork.com/doc/bc-platforms-launches-packaged-with-sentieon-to-accelerate-adoption-of-ngs-testing-0001,8/31/2021,"BC Platforms (BCP), a global leader in healthcare data management and analytics and US-based Sentieon, a developer of highly optimized algorithms for bioinformatics applications, today announced the launch of its new integrated next generation sequencing (NGS) genetic analytics software, known as BC|GENOME X-10."
Microbiologics Launches SARS-CoV-2 Whole Virus Antigen Controls For Point-Of-Care COVID-19 Diagnostics,https://www.laboratorynetwork.com/doc/microbiologics-launches-sars-cov-whole-virus-antigen-controls-for-point-of-care-covid-diagnostics-0001,8/31/2021,Microbiologics has launched a new SARS-CoV-2 quality control (QC) product designed for use with antigen point-of-care (POC) methods.
Vizgen Releases Commercial MERSCOPE Platform,https://www.laboratorynetwork.com/doc/vizgen-releases-commercial-merscope-platform-0001,8/30/2021,"Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced shipment of the first commercial MERSCOPETM Platforms, marking the successful start of their limited summer release program."
AnPac Bio’s USA Laboratory Receives Accreditation From The College Of American Pathologists,https://www.laboratorynetwork.com/doc/anpac-bio-s-usa-laboratory-receives-accreditation-from-the-college-of-american-pathologists-0001,8/30/2021,"AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that its Philadelphia, PA Clinical Laboratory Improvement Amendments (“CLIA”) certified laboratory has received accreditation from the College of American Pathologists (“CAP”)."
Visby Medical7™ Receives FDA Clearance And CLIA Waiver At The Point Of Care For PCR Sexual Health Test,https://www.laboratorynetwork.com/doc/visby-medical-trade-receives-fda-clearance-and-clia-waiver-at-the-point-of-care-for-pcr-sexual-health-test-0001,8/30/2021,"Visby Medical™ announced today that it has received a 510(k) clearance and was granted a waiver under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) from the US Food and Drug Administration (FDA) to market its fast, single-use polymerase chain reaction (PCR) diagnostic test for the multiplexed detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV), using a self-collected vaginal swab."
PreciseMDX Introduces New End-To-End Digital Health Platform That Automates And Simplifies Diagnostic Testing Experience,https://www.laboratorynetwork.com/doc/precisemdx-introduces-health-platform-that-automates-and-simplifies-diagnostic-testing-experience-0001,8/30/2021,"PreciseMDX, the leading end-to-end digital health platform, introduces a cloud-based solution that automates and simplifies the diagnostic testing experience, empowering labs to deliver a transformative journey to providers and patients."
"NIA Acquires PCR Machine, Alexandra Hospital Now Equipped To Do COVID-19 Testing",https://www.laboratorynetwork.com/doc/nia-acquires-pcr-machine-alexandra-hospital-now-equipped-to-do-covid-testing-0001,8/27/2021,The Nevis Island Administration (NIA) has secured a polymerase chain reaction (PCR) machine that will allow for COVID-19 testing to be carried out at the Alexandra Hospital laboratory on Nevis.
Biodesix DeSoto Laboratory Receives Both ISO 13485:2016 Certification And Accreditation From The College Of American Pathologists,https://www.laboratorynetwork.com/doc/biodesix-desoto-laboratory-both-iso-certification-accreditation-college-american-pathologists-0001,8/25/2021,"Biodesix, Inc. Today Biodesix announced that the Accreditation Committee of the College of American Pathologists (CAP) and British Standards Institute (BSI) on behalf of International Organization for Standardization (ISO) recently awarded both CAP accreditation and ISO 13485:2016 certification to the Biodesix Laboratory located in DeSoto, Kansas, based on results of two independent inspections conducted by CAP and BSI inspectors."
"Efficient, Low Maintenance Evaporator",https://www.laboratorynetwork.com/doc/efficient-low-maintenance-evaporator-0001,8/25/2021,Porvair Sciences announces that its Ultravap Mistral XT 150 blowdown evaporator is now able to operate at temperatures up to 80°C thereby significantly increasing the rate of evaporation of both organic solvents and aqueous solutions.
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform For U.S. Laboratories,https://www.laboratorynetwork.com/doc/bd-launches-fully-automated-high-throughput-molecular-diagnostic-platform-for-u-s-laboratories-0001,8/25/2021,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the United States."
Accenture Makes Strategic Investment In ixlayer To Expand Access To Virtual Diagnostic Health Testing,https://www.laboratorynetwork.com/doc/accenture-makes-strategic-investment-in-ixlayer-to-expand-access-to-virtual-diagnostic-health-testing-0001,8/24/2021,"Accenture has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and scalable health testing in a virtual environment."
QIAGEN Reaches Milestone With Its Kits Used To Process More Than Three Billion Biological Samples To Date,https://www.laboratorynetwork.com/doc/qiagen-reaches-milestone-with-its-kits-used-to-process-more-than-three-billion-biological-samples-to-date-0001,8/23/2021,"QIAGEN N.V.  today announced that the number of biological samples processed with consumables kits has passed the three billion mark – a record that underlines its leadership in enabling molecular laboratories to gain valuable insights in research, combatting diseases and forensics."
Todos Medical Completes Validation Of cPass Neutralizing Antibody Blood Test At Provista Diagnostics To Quantify And Monitor Key Biomarkers Of COVID-19 Immunity,https://www.laboratorynetwork.com/doc/todos-medical-completes-validation-at-provista-diagnostics-to-quantify-covid-immunity-0001,8/23/2021,"Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the cPass Neutralizing Antibody Blood Test into production and expects to launch cPass in September 2021."
Immunexpress Announces SeptiCyte® RAPID Testing For Paediatric Sepsis,https://www.laboratorynetwork.com/doc/immunexpress-announces-septicyte-rapid-testing-for-paediatric-sepsis-0001,8/23/2021,"Immunexpress, Pty Ltd, a molecular diagnostic company founded in Brisbane, today announced that the SeptiCyte® RAPID test will be evaluated in the diagnosis of paediatric sepsis in Queensland children."
Xybion Launches Digital Pathology For Research And Development,https://www.laboratorynetwork.com/doc/xybion-launches-digital-pathology-for-research-and-development-0001,8/23/2021,"Xybion Corporation, a global low-code SaaS company that enables digital transformation in highly regulated industries including Life Sciences announced the release of Pristima XD Digital Pathology."
"Genetron Health Reaches Strategic Partnership With Yikon Genomics, Expanding S5 Platform’s Reach To Reproductive Health Field",https://www.laboratorynetwork.com/doc/genetron-health-reaches-strategic-partnership-with-yikon-genomics-expanding-s-platform-s-reach-to-reproductive-health-field-0001,8/23/2021,"Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the signing of a strategic partnership with Shanghai Yikon Genomics Technology Co., Ltd. (“Yikon Genomics”), a company that focuses on reproductive health diagnostic testing."
Mitra Specimen Collection Devices Now Registered In China,https://www.laboratorynetwork.com/doc/mitra-specimen-collection-devices-now-registered-in-china-0001,8/19/2021,The Mitra® microsampling device from US-based Neoteryx is now registered as a Class I in vitro diagnostic (IVD) medical device with the Chinese Health Authority in China.
Highly Efficient Exosome Isolation & Purification Tools,https://www.laboratorynetwork.com/doc/highly-efficient-exosome-isolation-purification-tools-0001,8/17/2021,"AMSBIO is a knowledgeable supplier of products dedicated to exosome research that includes high quality reagents and kits that are quick, affordable and easy to use."
Karius Receives New York State Permit For Its Liquid Biopsy Test To Detect Infectious Diseases,https://www.laboratorynetwork.com/doc/karius-receives-new-york-state-permit-for-its-liquid-biopsy-test-to-detect-infectious-diseases-0001,8/17/2021,"Karius, the world leader in liquid biopsy for infectious diseases, has received approval from the New York State Department of Health's Clinical Laboratory Evaluation Program (CLEP) for its Karius Test for pathogen detection."
SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline,https://www.laboratorynetwork.com/doc/speedx-expand-sars-cov-variant-analysis-pipeline-0001,8/17/2021,"SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have expanded their product line of research reagents for COVID-19 variant analysis to include a mutation connected to the SARS-CoV-2 Delta variant of concern (VOC)."
Mirion Launches Lab-Pulse Internet Of Things Enabled Services For High Purity Germanium Systems,https://www.laboratorynetwork.com/doc/mirion-launches-lab-pulse-internet-enabled-services-for-high-purity-germanium-systems-0001,8/16/2021,"Mirion Technologies, Inc. (“Mirion”), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, today announced the launch of Mirion Lab-Pulse Services (“LabPulse Services”), a comprehensive value-based Internet of Things offering for High Purity Germanium systems to improve count room and laboratory uptime."
Fujifilm And ScreenPoint Medical Partner To Offer Providers With An AI Solution Designed For Early Breast Cancer Detection,https://www.laboratorynetwork.com/doc/fujifilm-and-screenpoint-medical-an-ai-solution-designed-for-early-breast-cancer-detection-0001,8/16/2021,"FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today announced that its ASPIRE Cristalle mammography system with digital breast tomosynthesis (DBT) now offers ScreenPoint Medical’s new, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States."
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business,https://www.laboratorynetwork.com/doc/bioreference-laboratories-acquires-u-s-ariosa-centralized-laboratory-prenatal-testing-business-0001,8/16/2021,"BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche."
Thermo Fisher Scientific Collaborates With ChromSword To Deliver Rapid Automated HPLC And UHPLC Method Development System,https://www.laboratorynetwork.com/doc/thermo-fisher-scientific-collaborates-to-deliver-rapid-automated-hplc-and-uhplc-system-0001,8/16/2021,"Thermo Fisher Scientific, the world leader in serving science, and ChromSword, a provider of innovative software products, have collaborated to launch an automated high performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) method development system that enables chromatographers to deliver robust and validated methods in less time and with higher confidence."
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval As Companion Diagnostic For TEPMETKO® (tepotinib),https://www.laboratorynetwork.com/doc/amoydx-pan-lung-cancer-pcr-panel-receives-mhlw-approval-as-companion-diagnostic-for-tepmetko-tepotinib-0001,8/16/2021,"Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for TEPMETKO® (tepotinib) a Merck KGaA, Darmstadt, Germany product that received approval by the Japanese MHLW in March 2020."
"Aditxt, Inc. And Great Lakes Medical Laboratory Launch AditxtScore For COVID-19 In State Of Michigan As A Personalized Approach To Addressing COVID-19 Pandemic",https://www.laboratorynetwork.com/doc/aditxt-inc-great-lakes-medical-laboratory-launch-covid-as-a-personalized-approach-pandemic-0001,8/11/2021,"Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with Great Lakes Medical Laboratory, Inc. (GLML), a full-service medical reference laboratory, to offer its AditxtScore for COVID-19 throughout the State of Michigan."
New BD Benchtop Cell Analyzer Enhances Laboratory Access And Accelerates Scientific Research,https://www.laboratorynetwork.com/doc/new-bd-benchtop-cell-analyzer-enhances-laboratory-access-and-accelerates-scientific-research-0001,8/11/2021,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes."
Genetron Health Tops NCCL’s External Quality Assessment Of NGS-Based Comprehensive Genomic Profiling For Solid Tumors With Full Marks,https://www.laboratorynetwork.com/doc/genetron-health-tops-nccl-s-external-quality-assessment-of-ngs-based-comprehensive-genomic-profiling-for-solid-tumors-with-full-marks-0001,8/11/2021,"Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that its Beijing clinical laboratory has received full marks under the National Center for Clinical Laboratories’ (“NCCL”) first nationwide, external quality assessment (“EQA”) of NGS-based comprehensive genomic profiling for solid tumors."
SYNLAB And IATA Partner To Facilitate Safe & Easy Travelling,https://www.laboratorynetwork.com/doc/synlab-and-iata-partner-to-facilitate-safe-easy-travelling-0001,8/11/2021,"SYNLAB to securely share certified COVID-19 test results with passengers directly through IATA Travel Pass, providing reliable digital proof on health status as international travel increases."
PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers,https://www.laboratorynetwork.com/doc/pavmed-subsidiary-lucid-diagnostics-launches-first-lucid-test-centers-0001,8/10/2021,"PAVmed Inc. (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its majority owned subsidiary Lucid Diagnostics Inc. (“Lucid”) has begun testing patients referred by primary care physicians (“PCPs”) at three Lucid Test Centers in the Phoenix metropolitan area."
StatLab Medical Products Acquires Pyramid Innovation,https://www.laboratorynetwork.com/doc/statlab-medical-products-acquires-pyramid-innovation-0001,8/10/2021,"StatLab Medical Products (“StatLab”), a leading developer and manufacturer of diagnostic supplies and equipment for the anatomic pathology market, has acquired Pyramid Innovation (“Pyramid”)."
INDICAID™ COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From The U.S. Food And Drug Administration,https://www.laboratorynetwork.com/doc/indicaid-covid-rapid-antigen-emergency-use-authorization-u-s-food-and-drug-administration-0001,8/10/2021,"PHASE Scientific International LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021."
Fulgent Genetics And Helio Health Announce Strategic Partnership To Commercialize Early Cancer Detection Tests,https://www.laboratorynetwork.com/doc/fulgent-genetics-and-helio-health-announce-strategic-cancer-detection-tests-0001,8/9/2021,"Fulgent Genetics, Inc. (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, and Helio Health (“Helio”), an AI-biotechnology company developing blood-based early cancer detection tests, today announced the companies have entered into a strategic partnership to commercialize Helio’s blood-based early cancer detection tests."
Dalrada Health And Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture,https://www.laboratorynetwork.com/doc/dalrada-health-and-vivera-pharmaceuticals-announce-new-diagnostic-laboratory-joint-venture-0001,8/9/2021,"To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation is excited to announce that its subsidiary, Dalrada Health, entered into a joint venture partnership with Vivera Pharmaceutical, Inc. (“Vivera”) to form Pala Diagnostics, LLC (“Pala Diagnostics”)."
Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel To Detect Delta And Lambda Variants,https://www.laboratorynetwork.com/doc/thermo-fisher-scientific-updates-customizable-taqman-sars-cov-delta-and-lambda-variants-0001,8/9/2021,"Thermo Fisher Scientific, the world leader in serving science, today announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains."
New Device Can Diagnose Covid-19 From Saliva Samples,https://www.laboratorynetwork.com/doc/new-device-can-diagnose-covid-from-saliva-samples-0001,8/6/2021,"Engineers at MIT and Harvard University have designed a small tabletop device that can detect SARS-CoV-2 from a saliva sample in about an hour. In a new study, they showed that the diagnostic is just as accurate as the PCR tests now used."
Ortho Clinical Diagnostics Expands COVID-19 Test Offerings With Emergency Use Authorization (EUA) Of Total Nucleocapsid Antibody Test,https://www.laboratorynetwork.com/doc/ortho-clinical-diagnostics-expands-covid-test-offerings-with-emergency-use-nucleocapsid-antibody-test-0001,8/5/2021,"Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its qualitative COVID-19 Total N antibody test received U.S. Food and Drug Administration EUA."
Next Generation Automation Lab Achieves Huge Productivity Gains,https://www.laboratorynetwork.com/doc/next-generation-automation-lab-achieves-huge-productivity-gains-0001,8/5/2021,"Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully automated Lilly Life Sciences Studio (L2S2) lab in San Diego, USA."
"Immunovia, Inc. Receives Approval To Begin Testing Patients For Pancreatic Cancer With The IMMray™ PanCan-d Test",https://www.laboratorynetwork.com/doc/immunovia-inc-receives-approval-to-begin-testing-patients-for-pancreatic-cancer-d-test-0001,8/4/2021,"Immunovia AB (publ) (""Immunovia""), a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced that Immunovia, Inc. has received final approval to begin patient testing for the IMMray PanCan-d test - the first blood test on the market dedicated to the early detection of pancreatic cancer."
"Mel-Mont Medical Announces The Validation Of Its Patented Self-Sampling Technology, Mía By XytoTest®, For Molecular Screening Using HPV-DNA And 7-Type mRNA E6/E7",https://www.laboratorynetwork.com/doc/mel-mont-medical-validation-of-its-patented-mia-by-xytotest-hpv-dna-and-type-mrna-e-e-0001,8/4/2021,"Mel-Mont Medical, a boutique medical device and technology company dedicated to improving women's health through the use of its DNA and mRNA patented self-sampling screening kit, Mia by XytoTest®, receives clinical validation as being equally effective to clinician-collected sampling."
Empower Clinics Completes Landmark Kai Laboratory Expansion,https://www.laboratorynetwork.com/doc/empower-clinics-completes-landmark-kai-laboratory-expansion-0001,8/4/2021,"Empower Clinics Inc. (""Empower"" or the ""Company"") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens is delighted to announce the completion of its Kai Medical Laboratory (""Kai Lab"") expansion."
Accelerate Diagnostics Announces CE Mark And Availability In Europe Of Fast Antimicrobial Susceptibility Test For Use With Existing ID Systems,https://www.laboratorynetwork.com/doc/accelerate-diagnostics-ce-mark-europe-antimicrobial-susceptibility-test-for-existing-id-systems-0001,8/3/2021,"Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest® BC kit has been CE marked and is ready for use in Europe."
Philips Genomics Workspace Enables Integration Of The Largest-Scale FDA-Cleared Cancer Genetic Test At NYU Langone Health,https://www.laboratorynetwork.com/doc/philips-genomics-workspace-enables-integration-test-at-nyu-langone-health-0001,8/3/2021,"Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that New York Langone Health’s Department of Pathology will leverage Philips Genomics Workspace (formerly part of IntelliSpace Precision Medicine Platform) to integrate into their EMR (electronic medical record) environment."
OpGen Achieves Key Development Milestone In Unyvero A30 RQ Platform Program,https://www.laboratorynetwork.com/doc/opgen-achieves-key-development-milestone-in-unyvero-a-rq-platform-program-0001,8/3/2021,"OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that its subsidiary Curetis GmbH and its instrument development and engineering partner have assembled 10 final pre-series release analyzer instruments of the Unyvero A30 RQ platform."
AXIM® Biotechnologies To Acquire Technology Including Two FDA-Cleared 510(k)’s For Diagnostic Testing Of Dry Eye Disease,https://www.laboratorynetwork.com/doc/axim-biotechnologies-to-acquire-technology-including-diagnostic-testing-of-dry-eye-disease-0001,8/3/2021,"AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing for COVID-19 and cancer, announced today that the Company has signed a Binding Term Sheet to acquire the technology for the testing of Dry Eye Disease (DED), including two FDA authorizations and approvals for the commercial sale of two ophthalmic diagnostic lab tests."
Myriad Genetics Expands Access To Genetic Testing With Launch Of First Polygenic Breast Cancer Risk Assessment Score Validated For Women Of All Ancestries,https://www.laboratorynetwork.com/doc/myriad-genetics-expands-access-assessment-score-validated-all-ancestries-0001,8/2/2021,"Advancing its mission to expand access to genetic testing, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched a new version of its market-leading MyRisk Hereditary Cancer Test."
TAAG Genetics Secures AOAC Validation For F41 VIP PCR Kit,https://www.laboratorynetwork.com/doc/taag-genetics-secures-aoac-validation-for-f-vip-pcr-kit-0001,8/2/2021,"TAAG Genetics announced today that its TAAG F41 VIP kit, a multiplex real-time PCR assay capable of detecting four separate foodborne pathogens in a single reaction, has been granted Performance Tested MethodsSM status from the AOAC Research Institute (certification #072101). AOAC promotes and conducts activities to help develop, improve, and validate proprietary testing methods."
FDA Clears Promega OncoMate MSI Dx Analysis System,https://www.laboratorynetwork.com/doc/fda-clears-promega-oncomate-msi-dx-analysis-system-0001,7/28/2021,Oncologists and pathologists in the United States can now access a new in vitro diagnostic (IVD) test that screens for Lynch syndrome in patients with colorectal cancer.
Eurofins Abraxis Announces The World’s First Rapid Glyphosate Method To Achieve AOAC Performance Test Method Certification Status,https://www.laboratorynetwork.com/doc/eurofins-abraxis-announces-the-worlds-first-rapid-glyphosate-method-to-achieve-status-0001,7/28/2021,"Eurofins Eurofins Abraxis, a developer, manufacturer and supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of Glyphosate, Eurofins Abraxis Glyphosate ELISA Kit, has been granted AOAC Research Institute Performance Tested Methods (PTM) status (AOAC Cert. No. 072104) for use with whole grain durum wheat, whole grain oats, oat groats, dried yellow peas, and dried red lentils."
"Together For The First Time, FUJIFILM Medical Systems U.S.A., Inc. And FUJIFILM Healthcare Americas Corporation Present Comprehensive Portfolio Of Medical Solutions At AHRA 2021",https://www.laboratorynetwork.com/doc/together-for-the-first-time-fujifilm-of-medical-solutions-at-ahra-0001,7/28/2021,"Fresh off its acquisition of Hitachi’s medical imaging business, FUJIFILM Medical Systems U.S.A., Inc. today announced that they will be exhibiting for the first time with FUJIFILM Healthcare Americas Corporation (formerly Hitachi’s Diagnostics imaging business) at the Association for Medical Imaging Management (AHRA) 2021 Annual Meeting and Exposition."
Ichor Blood Services Launches Quantitative COVID-19 Spike Protein Antibody Test Through The Mayo Clinic,https://www.laboratorynetwork.com/doc/ichor-blood-services-launches-quantitative-covid-spike-protein-antibody-test-through-the-mayo-clinic-0001,7/28/2021,"Ichor Blood Services, a private lab specimen collection company based in Calgary, Alberta has added quantitative COVID-19 spike protein antibody testing from the Mayo Clinic to its portfolio of privately available tests in Canada."
Covalent Metrology Expands Analytical Chemistry Capabilities With Triple-Quadrupole Inductively Coupled Plasma Mass Spectrometry (ICP-MS),https://www.laboratorynetwork.com/doc/covalent-metrology-expands-triple-quadrupole-inductively-coupled-plasma-mass-spectrometry-icp-ms-0001,7/27/2021,"Covalent Metrology, a leading North American provider of analytical services, announces an expansion of its chemical analysis capabilities with the install of a Thermo Scientific iCAP TQ for inductively coupled plasma mass spectroscopy (ICP-MS)."
GreyStone Labs In Irving Texas Provides Cutting Edge Services To Texas,https://www.laboratorynetwork.com/doc/greystone-labs-in-irving-texas-provides-cutting-edge-services-to-texas-0001,7/27/2021,
Galaxy Diagnostics Launches Broadest IFA Serology Panel Available For Bartonella Infection,https://www.laboratorynetwork.com/doc/galaxy-diagnostics-launches-broadest-ifa-serology-panel-available-for-bartonella-infection-0001,7/27/2021,"Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, today announced the launch of the most comprehensive Bartonella IFA Serology (IgG) Panel commercially available for human health testing."
"HealthTab™ Adds ID Now™ Molecular Test Device To Abbott Distribution Agreement, Now Offers First Real-Time Reporting Of SARS-CoV-2, Flu, Strep And RSV System In Pharmacy",https://www.laboratorynetwork.com/doc/healthtab-adds-id-now-molecular-reporting-of-sars-cov-flu-strep-and-rsv-system-in-pharmacy-0001,7/26/2021,"Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada."
PixCell Medical And Gamidor Diagnostics Partner To Introduce Point-Of-Care Hematology Analysis In Israel,https://www.laboratorynetwork.com/doc/pixcell-medical-and-gamidor-diagnostics-partner-to-introduce-point-of-care-hematology-analysis-in-israel-0001,7/26/2021,"PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced it has signed an exclusive distribution agreement with medical diagnostics company Gamidor Diagnostics to distribute the HemoScreen™, PixCell's hematology analyzer, across Israel. This deal follows a global shift spurred by the COVID-19 pandemic towards near-patient, digitally connected testing and diagnostics."
PathAI Enters Into Clinical Diagnostics Through Acquisition Of Poplar Healthcare Management,https://www.laboratorynetwork.com/doc/pathai-enters-into-clinical-diagnostics-through-acquisition-of-poplar-healthcare-management-0001,7/26/2021,"PathAI, a global provider of artificial intelligence-powered technology for pathology, announced their acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider."
"ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available In Canada",https://www.laboratorynetwork.com/doc/ortho-optix-reader-completes-transfusion-medicine-portfolio-now-available-in-canada-0001,7/26/2021,"Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in Canada."
PathogenDx Receives CE-IVD Mark For Its Microarray-Based DetectX-Rv Test For COVID-19,https://www.laboratorynetwork.com/doc/pathogendx-receives-ce-ivd-mark-for-its-microarray-based-detectx-rv-test-for-covid-0001,7/21/2021,"PathogenDx, Inc., an Arizona based biotechnology company which has developed a multiplexed microarray DNA-based pathogen testing platform, today announced that it has received the CE-IVD Mark for the sale and distribution of its patented DetectX-Rv Microarray Assay for COVID-19 testing across Europe. The CE-IVD mark is in conformance with the European Union In Vitro Diagnostic Directive 98/79/EC."
"AnchorDx's Non-Invasive Bladder Cancer Early Detection Test, UriFind, Earns ‘Breakthrough Device Designation’ From FDA",https://www.laboratorynetwork.com/doc/anchordx-s-non-invasive-bladder-cancer-early-detection-test-device-designation-from-fda-0001,7/21/2021,"AnchorDx, a world-leading developer of cancer screening and early detection solutions, on July 13, 2021, was awarded a Breakthrough Device Designation (""BTD"") by the US Food and Drug Administration (FDA) for UriFind (or ""the Test""), an early detection test for bladder cancer based on urine DNA methylation detection. This is the first BTD granted to liquid biopsy test for bladder cancer detection in China."
Unilabs Signs Deal With Ibex To Deploy AI-Powered Cancer Diagnostics,https://www.laboratorynetwork.com/doc/unilabs-signs-deal-with-ibex-to-deploy-ai-powered-cancer-diagnostics-0001,7/21/2021,"Unilabs, a leading international provider of diagnostic services, and Ibex Medical Analytics, the pioneer in artificial intelligence-powered cancer diagnostics, have agreed on a deal to implement Ibex's AI platform in pathology labs across Europe."
Grey Stone Labs In Texas: New Career Opportunities Available,https://www.laboratorynetwork.com/doc/grey-stone-labs-in-texas-new-career-opportunities-available-0001,7/21/2021,"Grey Stone Laboratories, based in Irving, Texas, is pleased to discuss the career opportunities available in their field. At the Grey Stone labs in Texas, due to the many different medical tests conducted, the company requires many different medical laboratory technicians as a part of their team."
Diagnostic Support Services (DS2) Selects Lyniate To Advance Innovation In Laboratory Settings,https://www.laboratorynetwork.com/doc/diagnostic-support-services-ds-selects-lyniate-to-advance-innovation-in-laboratory-settings-0001,7/20/2021,"Lyniate, the most trusted connector of healthcare worldwide, today announced that Diagnostic Support Services (DS2), a premier provider of data integration services to laboratories, has selected Lyniate Corepoint to enable advanced interoperability."
BD Seeks To Transform Patient Experience Through Vision Of 'One-Stick Hospital Stay',https://www.laboratorynetwork.com/doc/bd-seeks-to-transform-patient-experience-through-vision-of-one-stick-hospital-stay-0001,7/20/2021,"BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has taken a large step forward in transforming the patient experience through a vision of a ""One-Stick Hospital Stay,"" building on its history of innovation and leadership in blood collection and vascular access solutions."
LexaGene’s MiQLab Detects Common Bioreactor Contaminant Up To 300 Times Faster Than Conventional Methods,https://www.laboratorynetwork.com/doc/lexagene-s-miqlab-detects-common-bioreactor-contaminant-up-conventional-methods-0001,7/20/2021,"LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it has successfully utilized its MiQLab™ System (“MiQLab”) to detect the presence of mycoplasmas, a group of common microbial contaminants responsible for substantial losses in both time and money for biopharmaceutical manufacturers."
New 'Gold Standard' PCR Test To Travel Service Launched,https://www.laboratorynetwork.com/doc/new-gold-standard-pcr-test-to-travel-service-launched-0001,7/20/2021,A new 'gold' standard COVID-19 testing service has been launched today to enable people to take advantage of relaxed rules on foreign travel.
Todos Medical To Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement With Fosun Pharma,https://www.laboratorynetwork.com/doc/todos-medical-to-launch-eua-authorized-cpass-sars-cov-neutralizing-antibody-kit-pharma-0001,7/19/2021,"Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has entered into a distribution agreement with Fosun Pharma for the cPass™ SARS-CoV-2 Neutralizing Antibody Detection Kit that has received Emergency Use Authorization (“EUA”) from the US FDA for the detection of SARS-CoV-2 receptor binding domain (“RBD” or “neutralizing”) antibodies."
"Capital Digestive Care Partners With Colliers & Facility Logix To Expand Its Clinical Laboratory Footprint To 21,000 Square Feet",https://www.laboratorynetwork.com/doc/capital-digestive-care-partners-with-colliers-facility-logix-footprint-to-square-feet-0001,7/19/2021,"Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic, has partnered with Colliers International and Facility Logix to relocate and expand its laboratory in Silver Spring, Maryland."
A Noninvasive Test To Detect Cancer Cells And Pinpoint Their Location,https://www.laboratorynetwork.com/doc/a-noninvasive-test-to-detect-cancer-cells-and-pinpoint-their-location-0001,7/15/2021,"Most of the tests that doctors use to diagnose cancer — such as mammography, colonoscopy, and CT scans — are based on imaging. More recently, researchers have also developed molecular diagnostics that can detect specific cancer-associated molecules that circulate in bodily fluids like blood or urine."
Entry Level Semi Automatic Microplate Sealer,https://www.laboratorynetwork.com/doc/entry-level-semi-automatic-microplate-sealer-0001,7/14/2021,"Designed to be simple to operate, the new Ultraseal LITE semi-automatic microplate sealer from Porvair Sciences is the perfect device for labs with low to medium throughput (6 plates / minute) processing needs."
Hologic Obtains European CE Mark For Use Of Saliva Samples With COVID-19 Test,https://www.laboratorynetwork.com/doc/hologic-obtains-european-ce-mark-for-use-of-saliva-samples-with-covid-test-0001,7/14/2021,"Hologic, Inc. has obtained a CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in Europe. The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19. The test runs on the fully automated Panther system."
Pandemic Response Lab And Brio Announce Partnership To Provide Innovative Molecular Diagnostics Testing Solutions For The Entertainment Industry,https://www.laboratorynetwork.com/doc/pandemic-response-lab-molecular-diagnostics-testing-solutions-entertainment-industry-0001,7/13/2021,The Pandemic Response Lab (PRL) and Brio today announced they are partnering to provide COVID-19 testing and variant “zone” surveillance tracking to mitigate the risk of new and emerging variants for the entertainment industry.
LabVantage Solutions Introduces Secure Web Portal With Version 8.7 Of Its LabVantage LIMS Platform,https://www.laboratorynetwork.com/doc/labvantage-solutions-introduces-secure-web-portal-version-labvantage-lims-platform-0001,7/13/2021,"LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the 8.7 edition of its flagship LabVantage LIMS will provide a secure self-service web portal for the lab’s external clients."
Thermo Fisher Scientific And My Green Lab Collaborate To Expand Use Of ACT Label In Driving Environmentally Sustainable Lab Practices,https://www.laboratorynetwork.com/doc/thermo-fisher-scientific-and-my-green-lab-collaborate-label-in-sustainable-lab-practices-0001,7/13/2021,"Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of its collaboration with My Green Lab, a non-profit organization committed to improving the environmental sustainability of scientific research."
GT Molecular Launches Highly Sensitive PCR Tests For The SARS-CoV-2 Delta Variant And Influenza A/B,https://www.laboratorynetwork.com/doc/gt-molecular-launches-highly-sensitive-pcr-tests-for-the-sars-cov-delta-variant-and-influenza-a-b-0001,7/13/2021,
Quidel Receives CE Mark For Savanna Multiplex Molecular Analyzer And Respiratory Viral Panel,https://www.laboratorynetwork.com/doc/quidel-receives-ce-mark-savanna-multiplex-molecular-analyzer-respiratory-viral-panel-0001,7/12/2021,"Quidel Corporation (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the company has received the CE Mark for its innovative Savanna multiplex molecular analyzer and Savanna® RVP4 Assay (Respiratory Viral Panel-4)."
FluroTest Announces Pre-Emergency Use Authorization Filing With FDA; Provides Executive Update On Program Progress,https://www.laboratorynetwork.com/doc/flurotest-announces-pre-emergency-use-authorization-filing-with-fda-provides-executive-update-on-program-progress-0001,7/12/2021,"FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems (""FluroTest"" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announced it has filed its Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA)."
SpectraLIT™ - An Instant COVID-19 Testing Platform Enters Indian Market,https://www.laboratorynetwork.com/doc/spectralit-an-instant-covid-testing-platform-enters-indian-market-0001,7/12/2021,"MediCircle Health Pvt. Ltd., an AI-powered diagnostics company, is introducing the SpectraLIT™ - Spectral Instant Test in India, which is the world's fastest COVID-19 test delivering results in just one second."
"CaDi Introduces Lycobrain™, A First-In-Class Nutraceutical Targeting Tissue Oxygenation, With Supporting Point-Of-Care Diagnostic Blood Test",https://www.laboratorynetwork.com/doc/cadi-introduces-lycobrain-nutraceutical-targeting-tissue-oxygenation-diagnostic-blood-test-0001,7/12/2021,"Cambridge Diagnostic Imaging, CaDi, launches Lycobrain™, a first-in class nutraceutical to reboot and support brain functions, together with the development of a companion point-of-care diagnostic blood test for the assessment of tissue oxygenation."
Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First To Receive FDA Emergency Use Authorization,https://www.laboratorynetwork.com/doc/ortho-clinical-diagnostics-quantitative-covid-igg-antibody-fda-emergency-use-authorization-0001,7/9/2021,"Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA)."
QIAGEN’s NeuMoDx HAdV Quant Assay Secures CE-IVD Certification For Automated Testing To Detect Human Adenovirus Infections,https://www.laboratorynetwork.com/doc/qiagen-s-neumodx-certification-for-automated-testing-to-detect-human-adenovirus-infections-0001,7/8/2021,QIAGEN N.V. today announced that its NeuMoDx HAdV Quant Assay for the identification and quantification of human adenovirus (HAdV) DNA has received CE-IVD certification for the European Union and other countries that accept this marking.
Ischemia Care Announces Industry And Hospital Program To Support Molecular Diagnostic Testing In Ischemic Stroke,https://www.laboratorynetwork.com/doc/ischemia-care-industry-and-hospital-program-support-molecular-diagnostic-testing-ischemic-stroke-0001,7/8/2021,"Ischemia Care today announced a new program called “CLASSICS,” which stands for Clinical Laboratory and Strategic Support to Identify Stroke and Cause of Stroke to commercialize a portfolio of hospital-based blood tests across industry leading laboratory platforms for ischemic stroke and underlying causes (such as atrial fibrillation) used in the hospital setting."
Inventive Health: COVID-19 Detected In 20 Seconds By Ultra-Rapid Mouthwash Or Nasal Swab Test Using Spectral Analysis Under MHRA Approval,https://www.laboratorynetwork.com/doc/inventive-health-covid-detected-in-seconds-by-ultra-rapid-mouthwash-analysis-under-mhra-approval-0001,7/8/2021,"SpectraLIT™, an ultra-rapid pathogens diagnostic device able to test for SARS-CoV-2 within 20 seconds, is undergoing MHRA registration and, with approval expected imminently, will soon be available in the UK."
Ibex And Sana Kliniken Berlin-Brandenburg Partner To Bring AI-Powered Cancer Diagnostics To Germany,https://www.laboratorynetwork.com/doc/ibex-and-sana-kliniken-berlin-brandenburg-cancer-diagnostics-to-germany-0001,7/7/2021,"Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powered cancer diagnostics and Sana Kliniken Berlin-Brandenburg, part of Sana Kliniken AG - the third largest private hospital group in Germany, today announced the first deployment and clinical evaluation in Germany of an AI platform that supports pathologists during routine cancer diagnosis."
Ortho Clinical Diagnostics Announces Partnership With Thermo Fisher Scientific,https://www.laboratorynetwork.com/doc/ortho-clinical-diagnostics-announces-partnership-with-thermo-fisher-scientific-0001,7/7/2021,
BiologyWorks Awarded ISO 13485:2016 Certification For Development Of Its SARS-CoV-2 Fast Molecular Reusable Diagnostic Test,https://www.laboratorynetwork.com/doc/biologyworks-awarded-iso-certification-for-development-of-its-sars-cov-fast-molecular-reusable-diagnostic-test-0001,7/6/2021,"BiologyWorks, a medical test developer with a mission to deliver fast and accurate molecular testing, today announced that it has earned (ISO) 13485:2016 certification for its quality management processes in medical device manufacturing. BiologyWorks is the developer of the BiologyWorks k(now) test, a fast molecular test for qualitative detection of pathogens and molecular biomarkers for SARS-CoV-2 and other viruses and infections."
"Biocept Receives South Korean Patent For Primer-Switch Platform Used To Identify Rare Genetic Mutations, Including Cancer Biomarkers",https://www.laboratorynetwork.com/doc/biocept-receives-south-korean-patent-for-primer-switch-platform-used-including-cancer-biomarkers-0001,7/6/2021,"Biocept, Inc., a leading provider of molecular diagnostic assays and services, has been awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods."
